SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.55 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹2.74 Cr | ₹0.83 Cr |
What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.55 Cr |
Mar2023 | ₹0.55 Cr |
Mar2022 | ₹0.55 Cr |
Mar2017 | ₹2.74 Cr |
Mar2016 | ₹0.83 Cr |
How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.55 Cr | 0.00 | |
Mar2023 | ₹0.55 Cr | 0.00 | |
Mar2022 | ₹0.55 Cr | -79.96 | |
Mar2017 | ₹2.74 Cr | 231.80 | |
Mar2016 | ₹0.83 Cr | - |
Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,021.0 Cr | 0.3% | 26.8% | 81% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 0.3% |
26.8% |
81% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses